CTI Seeks ASP Payment For Zevalin; Medicare Cap Temporarily Lifted
This article was originally published in The Pink Sheet Daily
Executive Summary
Radioimmunotherapies shoud be reimbursed as biologic drugs, not radiopharmaceuticals, CTI CEO Bianco argues.
You may also be interested in...
CTI Will File sNDA For Zevalin In Follicular Lymphoma, CEO Bianco Tells DAILY
Improvement in progression-free survival is seen in patients with advanced follicular lymphoma following treatment with Zevalin.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.